9METERS BIOPHARMA Trademark

Trademark Overview

On Friday, August 9, 2019, a trademark application was filed for 9METERS BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the 9METERS BIOPHARMA trademark a serial number of 88573419. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, July 17, 2023. This trademark is owned by RDD Pharma, Inc.. The 9METERS BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for the treatment of anorectal diseases and gastrointestinal and liver disorders; Targeted pharmacological and biological treatments for anorectal diseases, liver, and gastrointestinal disorders such as fecal incontinence, pruritus ani, and radiation proctitis; Prescription and non-prescription pharmacological and biological treatments administered in various pharmaceutical technological forms, namely, in solid form pills, tablets, capsules, caplets, sachets, in semi-liquid form, namely, gels, ointments and pastes, suppositories, in liquid form, namely, drops, injectables, infusions, in gaseous form, namely, inhalants, or in sprays, namely, intranasally administered medications, for the treatment of anorectal diseases and gastrointestinal illnesses and disorders; Capsules sold empty for pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; ...
9meters biopharma

General Information

Serial Number88573419
Word Mark9METERS BIOPHARMA
Filing DateFriday, August 9, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, July 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements

Goods and ServicesPharmaceutical and biological preparations for the treatment of anorectal diseases and gastrointestinal and liver disorders; Targeted pharmacological and biological treatments for anorectal diseases, liver, and gastrointestinal disorders such as fecal incontinence, pruritus ani, and radiation proctitis; Prescription and non-prescription pharmacological and biological treatments administered in various pharmaceutical technological forms, namely, in solid form pills, tablets, capsules, caplets, sachets, in semi-liquid form, namely, gels, ointments and pastes, suppositories, in liquid form, namely, drops, injectables, infusions, in gaseous form, namely, inhalants, or in sprays, namely, intranasally administered medications, for the treatment of anorectal diseases and gastrointestinal illnesses and disorders; Capsules sold empty for pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Suppositories with proprietary delivery system for the precise delivery of drugs that target conditions and diseases of the anorectal region; Suppositories
Pseudo MarkNINE METERS BIO PHARMA
Disclaimer with Predetermined Text"BIOPHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 26, 2019
Primary Code005
First Use Anywhere DateWednesday, December 14, 2022
First Use In Commerce DateWednesday, December 14, 2022

Trademark Owner History

Party Name9 METERS BIOPHARMA
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressRALEIGH, NC 27615
Party NameRDD Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10019
Party NameRDD Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019

Trademark Events

Event DateEvent Description
Monday, July 17, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, July 17, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, July 17, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, March 31, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 31, 2023NON-FINAL ACTION E-MAILED
Friday, March 31, 2023SU - NON-FINAL ACTION - WRITTEN
Saturday, March 4, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, February 20, 2023USE AMENDMENT FILED
Monday, February 20, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, August 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 12, 2022SOU EXTENSION 5 GRANTED
Thursday, August 4, 2022SOU EXTENSION 5 FILED
Thursday, August 4, 2022TEAS EXTENSION RECEIVED
Saturday, March 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 5, 2022CORRECTED NOA E-MAILED
Friday, March 4, 2022SOU EXTENSION 4 GRANTED
Friday, February 11, 2022SOU EXTENSION 4 FILED
Friday, March 4, 2022DIVISIONAL PROCESSING COMPLETE
Friday, February 11, 2022DIVISIONAL REQUEST RECEIVED
Monday, February 28, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 11, 2022TEAS REQUEST TO DIVIDE RECEIVED
Friday, February 11, 2022TEAS EXTENSION RECEIVED
Wednesday, December 22, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, August 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 18, 2021SOU EXTENSION 3 GRANTED
Wednesday, August 18, 2021SOU EXTENSION 3 FILED
Wednesday, August 18, 2021TEAS EXTENSION RECEIVED
Saturday, December 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 10, 2020SOU EXTENSION 2 GRANTED
Thursday, December 10, 2020SOU EXTENSION 2 FILED
Thursday, December 10, 2020TEAS EXTENSION RECEIVED
Saturday, August 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 13, 2020SOU EXTENSION 1 GRANTED
Thursday, August 13, 2020SOU EXTENSION 1 FILED
Thursday, August 13, 2020TEAS EXTENSION RECEIVED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 18, 2019ASSIGNED TO LIE
Thursday, November 14, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 14, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, November 14, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 14, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, November 14, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, November 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 14, 2019NON-FINAL ACTION E-MAILED
Thursday, November 14, 2019NON-FINAL ACTION WRITTEN
Thursday, November 7, 2019ASSIGNED TO EXAMINER
Monday, August 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 13, 2019NEW APPLICATION ENTERED

Related Keywords

biopharma meters namely form capsules disorders gastrointestinal diseases biological anorectal pharmaceuticals pharmaceutical